Further to the Company’s announcement dated 8 October 2020 and Bursa Malaysia Securities Berhad’s query letter dated 9 October 2020 bearing reference no. IIQL-09102020-00003, the Company wishes to announce the following additional information:-
1) The terms of renewal were not stated in the Letter of Acceptance. The relevant terms and conditions will be announced once the formalisation of this Project has been completed and agreement has been signed with the Ministry of Health, Malaysia.
2) The Board of Directors does not foresee any exceptional risks other than the normal operational risks associated with this Project.
This announcement is dated 12 October 2020.